uniQure

Richard Porter, Ph.D., Chief Business Officer 

Oct. 11 | 2:15pm | UBC Ballroom 

Lexington, MA 

(NASDAQ: QURE) 

In-person Presentation 

uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease modifying therapies to patients with severe diseases. 

www.uniqure.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions